4-nitroquinoline-1-oxide has been researched along with 1-methylpropyl-2-imidazolyl disulfide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Cheng, B; Hu, Q; Wang, C; Wu, T; Xia, J; Yang, L | 1 |
1 other study(ies) available for 4-nitroquinoline-1-oxide and 1-methylpropyl-2-imidazolyl disulfide
| Article | Year |
|---|---|
Proteomics-based investigation of multiple stages of OSCC development indicates that the inhibition of Trx-1 delays oral malignant transformation.
Topics: 4-Nitroquinoline-1-oxide; Adult; Aged; Animals; Apoptosis; Biomarkers, Tumor; Carcinogenesis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Transformation, Neoplastic; Disulfides; Female; Humans; Imidazoles; Male; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Neoplasms, Experimental; Orthognathic Surgical Procedures; Oxidative Stress; Precancerous Conditions; Proteomics; Quinolones; Rats, Sprague-Dawley; Reactive Oxygen Species; Thioredoxins; Tongue | 2018 |